Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 1/2019

06.11.2018 | Original Article

U.S. Medical Examiner/Coroner capability to handle highly infectious decedents

verfasst von: Aurora B. Le, Erin G. Brooks, Lily A. McNulty, James R. Gill, Jocelyn J. Herstein, Janelle Rios, Scott J. Patlovich, Katelyn C. Jelden, Kendra K. Schmid, John J. Lowe, Shawn G. Gibbs

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

In the United States of America, Medical Examiners and Coroners (ME/Cs) investigate approximately 20% of all deaths. Unexpected deaths, such as those occurring due to a deceased person under investigation for a highly infectious disease, are likely to fall under ME/C jurisdiction, thereby placing the ME/C and other morgue personnel at increased risk of contracting an occupationally acquired infection. This survey of U.S. ME/Cs′ capabilities to address highly infectious decedents aimed to determine opportunities for improvement at ME/C facilities serving a state or metropolitan area. Data for this study was gathered via an electronic survey. Of the 177 electronic surveys that were distributed, the overall response rate was N = 108 (61%), with 99 of those 108 respondents completing all the questions within the survey. At least one ME/C responded from 47 of 50 states, and the District of Columbia. Select results were: less than half of respondents (44%) stated that their office had been involved in handling a suspected or confirmed highly infectious remains case and responses indicated medical examiners. Additionally, ME/C altered their personal protective equipment based on suspected versus confirmed highly infectious remains rather than taking an all-hazards approach. Standard operating procedures or guidelines should be updated to take an all-hazards approach, best-practices on handling highly infectious remains could be integrated into a standardized education, and evidence-based information on appropriate personal protective equipment selection could be incorporated into a widely disseminated learning module for addressing suspected or confirmed highly infectious remains, as those areas were revealed to be currently lacking.
Fußnoten
1
Respondents were able to select multiple options.
 
Literatur
3.
Zurück zum Zitat Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, et al. Infection control in the management of highly pathogenic infectious diseases: consensus of the European network of infectious disease. Lancet Infect Dis. 2009;9:301–11.CrossRef Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, et al. Infection control in the management of highly pathogenic infectious diseases: consensus of the European network of infectious disease. Lancet Infect Dis. 2009;9:301–11.CrossRef
4.
Zurück zum Zitat Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371:2402–9.CrossRef Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371:2402–9.CrossRef
5.
Zurück zum Zitat Chevalier MS, Chung W, Smith J, Weil LM, Hughes SM, Joyner SN, et al. Ebola virus disease cluster in the United States--Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1087–8.PubMedPubMedCentral Chevalier MS, Chung W, Smith J, Weil LM, Hughes SM, Joyner SN, et al. Ebola virus disease cluster in the United States--Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1087–8.PubMedPubMedCentral
6.
Zurück zum Zitat Hewlett AL, Varkey JB, Smith PW, Ribner BS. Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units. Curr Opin Infect Dis. 2015;28:343–8.CrossRef Hewlett AL, Varkey JB, Smith PW, Ribner BS. Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units. Curr Opin Infect Dis. 2015;28:343–8.CrossRef
7.
Zurück zum Zitat Kortepeter MG, Smith PW, Hewlett A, Cieslak TJ. Caring for patients with Ebola: a challenge in any care facility. Ann Intern Med. 2015;162:68–9.CrossRef Kortepeter MG, Smith PW, Hewlett A, Cieslak TJ. Caring for patients with Ebola: a challenge in any care facility. Ann Intern Med. 2015;162:68–9.CrossRef
8.
Zurück zum Zitat Johnson DW, Sullivan JN, Piquette CA, Hewlett AL, Bailey KL, Smith PW, et al. Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med. 2015;43:1157–64.CrossRef Johnson DW, Sullivan JN, Piquette CA, Hewlett AL, Bailey KL, Smith PW, et al. Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med. 2015;43:1157–64.CrossRef
9.
Zurück zum Zitat Schwedhelm S, Beam EL, Morris RD, Sebastian JG. Reflections on interprofessional team-based clinical care in the ebola epidemic: the Nebraska medicine experience. Nurs Outlook. 2015;63:27–9.CrossRef Schwedhelm S, Beam EL, Morris RD, Sebastian JG. Reflections on interprofessional team-based clinical care in the ebola epidemic: the Nebraska medicine experience. Nurs Outlook. 2015;63:27–9.CrossRef
10.
Zurück zum Zitat Herstein JJ, Biddinger PD, Kraft CS, Saiman L, Gibbs SG, Le AB, et al. Current capabilities and capacity of ebola treatment centers in the United States. Infect Control Hosp Epidemiol. 2016;37:313–8.CrossRef Herstein JJ, Biddinger PD, Kraft CS, Saiman L, Gibbs SG, Le AB, et al. Current capabilities and capacity of ebola treatment centers in the United States. Infect Control Hosp Epidemiol. 2016;37:313–8.CrossRef
11.
Zurück zum Zitat Isakov A, Jamison A, Miles W, Ribner B. Safe management of patients with serious communicable diseases: recent experience with Ebola virus. Ann Intern Med. 2014;161:829–30.CrossRef Isakov A, Jamison A, Miles W, Ribner B. Safe management of patients with serious communicable diseases: recent experience with Ebola virus. Ann Intern Med. 2014;161:829–30.CrossRef
12.
Zurück zum Zitat Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374:636–46.CrossRef Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374:636–46.CrossRef
13.
Zurück zum Zitat Lowe JJ, Gibbs SG, Schwedhelm SS, Nguyen J, Smith PW. Nebraska biocontainment unit perspective on disposal of Ebola medical waste. Am J Infect Control. 2014;42:1256–7.CrossRef Lowe JJ, Gibbs SG, Schwedhelm SS, Nguyen J, Smith PW. Nebraska biocontainment unit perspective on disposal of Ebola medical waste. Am J Infect Control. 2014;42:1256–7.CrossRef
14.
Zurück zum Zitat Lowe JJ, Jelden KC, Schenarts PJ, Rupp LE, Hawes KJ, Tysor BM, et al. Considerations for safe EMS transport of patients infected with Ebola virus. Prehosp Emerg Care. 2015;19:179–83.CrossRef Lowe JJ, Jelden KC, Schenarts PJ, Rupp LE, Hawes KJ, Tysor BM, et al. Considerations for safe EMS transport of patients infected with Ebola virus. Prehosp Emerg Care. 2015;19:179–83.CrossRef
15.
Zurück zum Zitat Isakov A, Miles W, Gibbs S, Lowe J, Jamison A, Swansiger R. Transport and management of patients with confirmed or suspected Ebola virus disease. Emerg Med. 2015;66:297–305. Isakov A, Miles W, Gibbs S, Lowe J, Jamison A, Swansiger R. Transport and management of patients with confirmed or suspected Ebola virus disease. Emerg Med. 2015;66:297–305.
16.
Zurück zum Zitat Jelden KC, Iwen PC, Herstein JJ, Biddinger PD, Kraft CS, Saiman L, et al. US Ebola treatment center clinical laboratory support. J Clin Microbiol. 2016;54:1031–5.CrossRef Jelden KC, Iwen PC, Herstein JJ, Biddinger PD, Kraft CS, Saiman L, et al. US Ebola treatment center clinical laboratory support. J Clin Microbiol. 2016;54:1031–5.CrossRef
17.
Zurück zum Zitat Jelden KC, Gibbs SG, Smith PW, Schwedhelm MM, Iwen PC, Beam EL, et al. Nebraska biocontainment unit patient discharge and environmental decontamination after Ebola care. Am J Infect Control. 2015;43:203–5.CrossRef Jelden KC, Gibbs SG, Smith PW, Schwedhelm MM, Iwen PC, Beam EL, et al. Nebraska biocontainment unit patient discharge and environmental decontamination after Ebola care. Am J Infect Control. 2015;43:203–5.CrossRef
19.
Zurück zum Zitat Fitzpatrick G, Vogt F, Moi Gbabai OB, Decroo T, Keane M, De Clerck H, et al. The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins sans Frontieres Ebola case management Centre, Kailahun, Sierra Leone, June–October 2014. J Infect Dis. 2015;212:1752–8.CrossRef Fitzpatrick G, Vogt F, Moi Gbabai OB, Decroo T, Keane M, De Clerck H, et al. The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins sans Frontieres Ebola case management Centre, Kailahun, Sierra Leone, June–October 2014. J Infect Dis. 2015;212:1752–8.CrossRef
20.
Zurück zum Zitat Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, et al. Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Eur Secur. 2017;22:17–00088. Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, et al. Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Eur Secur. 2017;22:17–00088.
21.
Zurück zum Zitat Le AB, Witter L, Herstein JJ, Jelden KC, Beam EL, Gibbs SG, et al. A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management. J Occup Environ Hyg. 2017;14:674–80.CrossRef Le AB, Witter L, Herstein JJ, Jelden KC, Beam EL, Gibbs SG, et al. A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management. J Occup Environ Hyg. 2017;14:674–80.CrossRef
23.
Zurück zum Zitat Blau DM, Clark SC, Nolte KB. Infectious disease surveillance by medical examiners and coroners. Emerg Infect Dis. 2013;19:821.PubMedPubMedCentral Blau DM, Clark SC, Nolte KB. Infectious disease surveillance by medical examiners and coroners. Emerg Infect Dis. 2013;19:821.PubMedPubMedCentral
25.
Zurück zum Zitat Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, Armbrustmacher V. The pathology of human West Nile virus infection. Hum Pathol. 2000;31:527–31.CrossRef Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, Armbrustmacher V. The pathology of human West Nile virus infection. Hum Pathol. 2000;31:527–31.CrossRef
26.
Zurück zum Zitat Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol. 1995;26:110–20.CrossRef Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol. 1995;26:110–20.CrossRef
27.
Zurück zum Zitat Li L, Gu J, Shi X, Gong E, Li X, Shao H, et al. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects. Clin Infect Dis. 2005;41:815–21.CrossRef Li L, Gu J, Shi X, Gong E, Li X, Shao H, et al. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects. Clin Infect Dis. 2005;41:815–21.CrossRef
29.
Zurück zum Zitat Fitzpatrick G, Decroo T, Draguez B, Crestani R, Ronsse A, Van den Bergh R, et al. Operational research during the Ebola emergency. Emerg Infect Dis. 2017;23:1057–62.CrossRef Fitzpatrick G, Decroo T, Draguez B, Crestani R, Ronsse A, Van den Bergh R, et al. Operational research during the Ebola emergency. Emerg Infect Dis. 2017;23:1057–62.CrossRef
30.
Zurück zum Zitat Singh VD, Lathrop SL. Role of the medical examiner in zika virus and other emerging infections. Arch Pathol Lab Med. 2016;141:82–4.CrossRef Singh VD, Lathrop SL. Role of the medical examiner in zika virus and other emerging infections. Arch Pathol Lab Med. 2016;141:82–4.CrossRef
31.
Zurück zum Zitat Zaki S, Blau DM, Hughes JM, Nolte KB, Lynfield R, Carr W, et al. CDC grand rounds: discovering new diseases via enhanced partnership between public health and pathology experts. MMWR Morb Mortal Wkly Rep. 2014;63:121–6.PubMedPubMedCentral Zaki S, Blau DM, Hughes JM, Nolte KB, Lynfield R, Carr W, et al. CDC grand rounds: discovering new diseases via enhanced partnership between public health and pathology experts. MMWR Morb Mortal Wkly Rep. 2014;63:121–6.PubMedPubMedCentral
32.
Zurück zum Zitat Nolte KB, Shieh W, Zaki SR. Emerging infectious diseases and the medical examiner. 2nd ed. Northfield: CAP Press; 2003. Nolte KB, Shieh W, Zaki SR. Emerging infectious diseases and the medical examiner. 2nd ed. Northfield: CAP Press; 2003.
33.
Zurück zum Zitat Nolte KB, Hanzlick RL, Pyan DC, Kroger AT, Oliver WR, Baker AM, et al. Medical examiners, coroners, and biologic terrorism. MMWR Morb Mortal Wkly Rep. 2004;53:1–27. Nolte KB, Hanzlick RL, Pyan DC, Kroger AT, Oliver WR, Baker AM, et al. Medical examiners, coroners, and biologic terrorism. MMWR Morb Mortal Wkly Rep. 2004;53:1–27.
38.
Zurück zum Zitat Wenner L, Pauli U, Summermatter K, Gantenbein H, Vidondo B, Posthaus H. Aerosol generation during bone-sawing procedures in veterinary autopsies. Vet Pathol. 2017;54:425–36.CrossRef Wenner L, Pauli U, Summermatter K, Gantenbein H, Vidondo B, Posthaus H. Aerosol generation during bone-sawing procedures in veterinary autopsies. Vet Pathol. 2017;54:425–36.CrossRef
39.
Zurück zum Zitat Nolte KB, Taylor DG, Richmond JY. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002;23:107–22.CrossRef Nolte KB, Taylor DG, Richmond JY. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002;23:107–22.CrossRef
40.
Zurück zum Zitat Lindsley WG, Noti JD, Blachere FM, Szalajda JV, Beezhold DH. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg. 2014;11:509–18.CrossRef Lindsley WG, Noti JD, Blachere FM, Szalajda JV, Beezhold DH. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg. 2014;11:509–18.CrossRef
41.
Zurück zum Zitat Hon CY, Gamage B, Bryce EA, LoChang J, Yassi A, Maultsaid D, et al. Personal protective equipment in health care: can online infection control courses transfer knowledge and improve proper selection and use? Am J Infect Control. 2008;36:e33–e7.CrossRef Hon CY, Gamage B, Bryce EA, LoChang J, Yassi A, Maultsaid D, et al. Personal protective equipment in health care: can online infection control courses transfer knowledge and improve proper selection and use? Am J Infect Control. 2008;36:e33–e7.CrossRef
42.
Zurück zum Zitat Miller MJ, Astles R, Baszler T, Chapin K, Carey R, Garcia L, et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. MMWR Surveill Summ. 2012;6:1–102. Miller MJ, Astles R, Baszler T, Chapin K, Carey R, Garcia L, et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. MMWR Surveill Summ. 2012;6:1–102.
43.
Zurück zum Zitat Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, et al. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016;42:34–9.CrossRef Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, et al. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016;42:34–9.CrossRef
Metadaten
Titel
U.S. Medical Examiner/Coroner capability to handle highly infectious decedents
verfasst von
Aurora B. Le
Erin G. Brooks
Lily A. McNulty
James R. Gill
Jocelyn J. Herstein
Janelle Rios
Scott J. Patlovich
Katelyn C. Jelden
Kendra K. Schmid
John J. Lowe
Shawn G. Gibbs
Publikationsdatum
06.11.2018
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 1/2019
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-0043-2

Weitere Artikel der Ausgabe 1/2019

Forensic Science, Medicine and Pathology 1/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …